|
||||||||||||||||||
From: TSS ()
New Generation BSE test approved by CFIA A breakthrough in BSE testing, the Prionics®-Check PrioSTRIP combines speed with reliability. The test, which represents an innovative mass-screening application of the proven lateral flow technology, is simple, easy and fast providing results in about 100 minutes. It received EU approval in February 2005 and has been successfully introduced in European laboratories. The Prionics®-Check PrioSTRIP represents a considerable improvement over existing BSE testing platforms, which typically deliver results between 4 and 5 ˝ hours. It allows high throughput processing with minimal requirements for specialized equipment. Also, the use of the Prionics®-Check PrioSTRIP requires only minimal training of laboratory personnel while delivering the highest standards of sensitivity and specificity. 16.06.2005 © Copyright by Prionics AG, Switzerland http://prionics.com/online/news/e-p200506150556604779-050615stripcdnen_v2.pdf http://prionics.com/prionics-e.htm TSS Date : Friday - June 17, 2005 ZURICH, Switzerland, June 17 /CNW/ - Prionics AG announced today that the Canadian Food Inspection Agency (CFIA) has granted approval of the Prionics(R)-Check PrioSTRIP, the latest generation of testing technology for Bovine Spongiform Encephalopathy (BSE). A breakthrough in BSE testing, the Prionics(R)-Check PrioSTRIP combines speed with reliability. The test, which represents an innovative mass- screening application of the proven lateral flow technology, is simple, easy and fast providing results in about 100 minutes. It received EU approval in February 2005 and has been successfully introduced in European laboratories. The Prionics(R)-Check PrioSTRIP represents a considerable improvement over existing BSE testing platforms, which typically deliver results between 4 to 5 1/2 hours. It allows high throughput processing with minimal requirements for specialized equipment. Also, the use of the Prionics(R)-Check PrioSTRIP requires only minimal training of laboratory personnel while delivering the highest standards of sensitivity and specificity. "The combined benefits of the new PrioSTRIP help to significantly reduce operation costs," says Ernst Zollinger, head of marketing and sales at Prionics. "BSE-testing has never been more efficient." About Prionics Prionics AG is the world leader in BSE testing, with approximately 50% market share of the world BSE testing market. Prionics is the only company that has developed and launched three independent BSE testing platforms approved by the EU. The Prionics(R)-Check product family consists of the Prionics(R)-Check WESTERN, Prionics(R)-Check LIA and Prionics(R)-Check PrioSTRIP. The different platforms are compatible and share the sample preparation procedure. The Prionics(R)-Check WESTERN and the Prionics(R)-Check LIA have been approved for use by the United States Department of Agriculture (USDA). In January 2004, the Canadian Food inspection Agency (CFIA) chose Prionics(R)-Check WESTERN for the federal enhanced BSE disease surveillance program. http://press.arrivenet.com/pro/article.php/655525.html
|